Patents by Inventor Noah NELSON

Noah NELSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250302988
    Abstract: The present invention relates to novel therapeutic nanoparticles. In particular, the present invention is directed to nanoparticles associated (e.g., complexed, conjugated, encapsulated, absorbed, adsorbed, admixed) with angiogenesis-activating-agents, methods of synthesizing the same, devices or compositions comprising such nanoparticles, as well as systems and methods utilizing the nanoparticles (e.g., in therapeutic settings for enhancing and/or activating angiogenesis at targeted tissue region).
    Type: Application
    Filed: June 16, 2025
    Publication date: October 2, 2025
    Inventors: Steven R. BUCHMAN, Mark COHEN, Alexis DONNEYS, Noah NELSON, Laird FORREST, Ti ZHANG, Qiuhong YANG
  • Patent number: 12329827
    Abstract: The present invention relates to novel therapeutic nanoparticles. In particular, the present invention is directed to nanoparticles associated (e.g., complexed, conjugated, encapsulated, absorbed, adsorbed, admixed) with angiogenesis-activating-agents, methods of synthesizing the same, devices or compositions comprising such nanoparticles, as well as systems and methods utilizing the nanoparticles (e.g., in therapeutic settings for enhancing and/or activating angiogenesis at targeted tissue region).
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: June 17, 2025
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, THE UNIVERSITY OF KANSAS
    Inventors: Steven R. Buchman, Mark Cohen, Alexis Donneys, Noah Nelson, Laird Forrest, Ti Zhang, Qiuhong Yang
  • Publication number: 20210322569
    Abstract: The present invention relates to novel therapeutic nanoparticles. In particular, the present invention is directed to nanoparticles associated (e.g., complexed, conjugated, encapsulated, absorbed, adsorbed, admixed) with angiogenesis-activating-agents, methods of synthesizing the same, devices or compositions comprising such nanoparticles, as well as systems and methods utilizing the nanoparticles (e.g., in therapeutic settings for enhancing and/or activating angiogenesis at targeted tissue region).
    Type: Application
    Filed: June 22, 2021
    Publication date: October 21, 2021
    Inventors: Steven R. BUCHMAN, Mark COHEN, Alexis DONNEYS, Noah NELSON, Laird FORREST, Ti ZHANG, Qiuhong YANG
  • Patent number: 11045556
    Abstract: The present invention relates to novel therapeutic nanoparticles. In particular, the present invention is directed to nanoparticles associated (e.g., complexed, conjugated, encapsulated, absorbed, adsorbed, admixed) with angiogenesis-activating-agents, methods of synthesizing the same, devices or compositions comprising such nanoparticles, as well as systems and methods utilizing the nanoparticles (e.g., in therapeutic settings for enhancing and/or activating angiogenesis at targeted tissue region).
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: June 29, 2021
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, THE UNIVERSITY OF KANSAS
    Inventors: Steven R. Buchman, Mark Cohen, Alexis Donneys, Noah Nelson, Laird Forrest, Ti Zhang, Qiuhong Yang
  • Publication number: 20190008984
    Abstract: The present invention relates to novel therapeutic nanoparticles. In particular, the present invention is directed to nanoparticles associated (e.g., complexed, conjugated, encapsulated, absorbed, adsorbed, admixed) with angiogenesis-activating-agents, methods of synthesizing the same, devices or compositions comprising such nanoparticles, as well as systems and methods utilizing the nanoparticles (e.g., in therapeutic settings for enhancing and/or activating angiogenesis at targeted tissue region).
    Type: Application
    Filed: December 16, 2016
    Publication date: January 10, 2019
    Inventors: Steven R. BUCHMAN, Mark COHEN, Alexis DONNEYS, Noah NELSON, Laird FORREST, Ti ZHANG, Qiuhong YANG